Skip to content



Emerson Hospital meeting: Innovations in breast cancer screening, treatment


CONCORD — The annual meeting of the Emerson Hospital Auxiliary will be held on Thursday, Oct. 30, from 11 a.m. to 2 p.m. at the Nashawtuc Country Club, 1861 Sudbury Road, Concord. The public is invited to attend.

Timed with October’s Breast Cancer Awareness month, this year’s event will feature Dr. David Rose, chair of Radiology and director of Breast Imaging at Emerson Hospital and president of the North Bridge Imaging Group.

The title of Dr. Rose’s program is “The Changing Landscape of Mammography: Innovations in Breast Cancer Screening and Treatment.”

Dr. Rose will talk about the latest advances in mammography using tomosynthesis (3D mammography) augmented by ultrasound, breast MRI, and other diagnostic services.

Breast tomosynthesis takes multiple images of the entire breast, allowing radiologists to see through layers of tissue and examine areas of concern from all angles. Use of this technology may make breast cancers easier to see in dense breast tissue.

All aspects of breast health and care, including screening, diagnosis, and treatment are part of the comprehensive range of services offered by Emerson’s Hermel Breast Health Center and the Mass General Cancer Center at Emerson Hospital — Bethke.

Staff from Emerson’s Hermel Breast Health Center will also be present to educate attendees on breast self exams and answer questions about mammography. The event will begin at 11 a.m. with time to socialize, followed by lunch, a brief business meeting, and Dr. Rose’s talk. Tickets are $30, and include lunch. They can be purchased by contacting Auxiliary President Sally Savelle at or at 978-287-4827.

Join the Conversation

We invite you to use our commenting platform to engage in insightful conversations about issues in our community. We reserve the right at all times to remove any information or materials that are unlawful, threatening, abusive, libelous, defamatory, obscene, vulgar, pornographic, profane, indecent or otherwise objectionable to us, and to disclose any information necessary to satisfy the law, regulation, or government request. We might permanently block any user who abuses these conditions.